Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeBiotech

      Biotech

      Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program
      Biotech

      Monument Therapeutics Announces Appointment of Dr Stephen Brannan, Dr Jeff Baker and Dr Mark Treherne to its Advisory Board to Guide Schizophrenia Program

      November 19, 2024
      Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE
      Biotech

      Roche receives CE Mark for VENTANA FOLR1 (FOLR1-2.1) RxDx Assay as the first IHC-based companion diagnostic to identify ovarian cancer patients eligible for ELAHERE

      November 18, 2024
      Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC
      Biotech

      Bexion Pharmaceuticals, Inc. Announces Completion of Enrollment in Open Label Portion of Phase 1b/2 ASIST Study in mCRC

      November 18, 2024
      AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024
      Biotech

      AbelZeta Presents Preclinical Data from Study of C-CAR168 for the Treatment of Autoimmune Diseases at ACR Convergence 2024

      November 17, 2024
      SHORELINE BIOSCIENCES TO PRESENT AT 2024 STIFEL HEALTHCARE CONFERENCE
      Biotech

      SHORELINE BIOSCIENCES TO PRESENT AT 2024 STIFEL HEALTHCARE CONFERENCE

      November 16, 2024
      Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics to drive revenue, Report with the AI impact on market trends – Technavio
      Biotech

      Biosimilars Market to grow by USD 54.35 billion (2024-2028), cost advantage over biologics to drive revenue, Report with the AI impact on market trends – Technavio

      November 16, 2024
      FDA Roundup: November 15, 2024
      Biotech

      FDA Roundup: November 15, 2024

      November 16, 2024
      Precigen Reports Third Quarter 2024 Financial Results and Business Updates
      Biotech

      Precigen Reports Third Quarter 2024 Financial Results and Business Updates

      November 15, 2024
      Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer
      Biotech

      Harbour BioMed Appoints Dr. Raymond Zheng as Chief Business Officer

      November 15, 2024
      Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial
      Biotech

      Xeltis announces FDA Breakthrough Device Designation for aXessTM and first patient treated in US pivotal trial

      November 14, 2024
      « 1 … 65 66 67 68 69 … 140 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026